Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Award from the journal Hypertension recognises publication as the top paper in its category of basic science.

The work was led by Dr Gillian Douglas and Professor Keith Channon (pictured left) and the first author was Dr Surawee Chuaiphichai (pictured right). 

The award comes with a cash prize, two inscribed plaques and a travel award to attend the Council on Hypertension Scientific Sessions 2019 in New Orleans, Louisiana from September 5 - 8 2019. 

The paper, entitled 'Hypertension for the paper Endothelial cell tetrahydrobiopterin modulates sensitivity to Ang (angiotensin) II–induced vascular remodeling, blood pressure, and abdominal aortic aneurysm. can be read here

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Enterprise Associate Interview with Dr Shilpa Nagarajan

Dr Shilpa Nagarajan is one of the MPLS Enterprise and Innovation Fellows for 2022-23.

The Gene Therapists Headline at Glastonbury 2022

Rosie Munday writes about her experience taking science to the masses at the Glastonbury Festival.

Intensive blood glucose control for people with type 2 diabetes when they are first diagnosed reduces diabetic complications and prolongs life

The study, which tracked volunteers for up to 44 years, showed that the benefits of early intensive blood glucose control can persist for decades.

Wellcome Trust funding success for Jim Hughes and James Davies

£3.6 million in funding awarded by the Wellcome Trust to combine cutting-edge 3D genome technologies with machine learning approaches to decipher the role of the non-coding genome in disease.

Study develops radiotranscriptomic AI analysis to enable virtual heart biopsies

RDM researchers tested the method in COVID-19 patients, to find that the results predicted in-hospital mortality.